Portage Biotech Inc (PRTG)
NASDAQ:PRTG
US Market
Holding PRTG?
Track your performance easily

Portage Biotech Inc (PRTG) Financial Statements

74 Followers

Portage Biotech Inc Financial Overview

Portage Biotech Inc's market cap is currently ―. The company's EPS TTM is $-70.217; its P/E ratio is -0.09; Portage Biotech Inc is scheduled to report earnings on November 26, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue---$ 0.00$ 0.00
Gross Profit-----
EBIT$ -48.87M--$ -5.30M$ -3.63M
EBITDA$ -48.85M--$ -5.30M$ -3.63M
Net Income Common Stockholders$ -39.38M$ -5.16M-$ -7.49M$ -949.00K
Balance Sheet-
Cash Cash Equivalents And Short Term Investments$ 5.34M$ 3.44M$ 10.54M$ 13.10M$ 15.04M
Total Assets$ 49.03M$ 92.40M$ 99.13M$ 210.68M$ 216.53M
Total Debt$ 275.00K$ 286.00K$ 0.00$ 0.00$ 0.00
Net Debt$ -5.07M$ -3.16M$ -10.54M$ -13.10M$ -15.04M
Total Liabilities$ 17.70M$ 25.40M$ 23.73M$ 42.38M$ 38.72M
Stockholders Equity$ 32.00M$ 67.66M$ 76.05M$ 168.94M$ 178.43M
Cash Flow-
Free Cash Flow$ -3.43M--$ -2.70M$ -2.52M
Operating Cash Flow$ -3.43M--$ -2.70M$ -2.51M
Investing Cash Flow---$ 0.00-
Financing Cash Flow$ 5.33M--$ 770.00K$ -3.01M
Currency in USD

Portage Biotech Inc Earnings and Revenue History

Portage Biotech Inc Debt to Assets

Portage Biotech Inc Cash Flow

Portage Biotech Inc Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis